Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder
- PMID: 26348088
- PMCID: PMC4576946
- DOI: 10.1089/cap.2015.0041
Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder
Abstract
Objective: The purpose of this study was to investigate the effect of sertraline (SRT) in children and adolescents with obsessive-compulsive disorder (OCD) who did not respond to two consecutive courses of cognitive-behavior therapy (CBT).
Methods: Observational study with 11 participants (males, n=6), 7-17 years of age with Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) primary OCD. All had received 14 plus 10 sessions of CBT over the course of 218-532 days (mean=342.2, SD=85.5). Outcome measures were mean reduction of the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) total score and adequate clinical response (CY-BOCS<16). All participants received SRT (maximum dose 200 mg/day). The study was a part of the Nordic Long-Term OCD Treatment Study (NordLOTS).
Results: Participants were treated with SRT over 72-300 days (mean=164.2, SD=68.3). The mean CY-BOCS score was reduced from 21.5 (SD=2.6) to 17.5 (SD=3.3). Only three participants obtained adequate clinical response (27.2%), and only two obtained >25% CY-BOCS total score reduction (close to 50%).
Conclusions: A clinical response in approximately one third of the participants suggests that SRT treatment might be beneficial to a minority of patients who have consistently failed CBT.
Figures
Similar articles
-
Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.Eur Child Adolesc Psychiatry. 2015 May;24(5):591-602. doi: 10.1007/s00787-014-0613-0. Epub 2014 Sep 20. Eur Child Adolesc Psychiatry. 2015. PMID: 25239489 Free PMC article. Clinical Trial.
-
Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.J Child Adolesc Psychopharmacol. 2015 Jun;25(5):432-9. doi: 10.1089/cap.2014.0167. J Child Adolesc Psychopharmacol. 2015. PMID: 26091197 Free PMC article. Clinical Trial.
-
Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.JAMA. 2004 Oct 27;292(16):1969-76. doi: 10.1001/jama.292.16.1969. JAMA. 2004. PMID: 15507582 Clinical Trial.
-
Comparing the efficacy of pharmacological and psychological treatment, alone and in combination, in children and adolescents with obsessive-compulsive disorder: A network meta-analysis.J Psychiatr Res. 2022 Apr;148:95-102. doi: 10.1016/j.jpsychires.2022.01.057. Epub 2022 Jan 29. J Psychiatr Res. 2022. PMID: 35121274 Review.
-
The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis.Front Psychiatry. 2019 Aug 6;10:523. doi: 10.3389/fpsyt.2019.00523. eCollection 2019. Front Psychiatry. 2019. PMID: 31447707 Free PMC article.
Cited by
-
Advances in Pediatric Obsessive-Compulsive Disorder (OCD) Treatment: A Comprehensive Narrative Review.Cureus. 2024 Aug 30;16(8):e68225. doi: 10.7759/cureus.68225. eCollection 2024 Aug. Cureus. 2024. PMID: 39221295 Free PMC article. Review.
-
Specific Contamination Symptoms are Associated with Experiencing a Limited Response of Cognitive-Behavioral Therapy in Pediatric Patients with OCD.Child Psychiatry Hum Dev. 2024 Aug;55(4):1135-1145. doi: 10.1007/s10578-022-01480-y. Epub 2022 Dec 12. Child Psychiatry Hum Dev. 2024. PMID: 36510026
-
Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial.JAMA. 2021 May 11;325(18):1863-1873. doi: 10.1001/jama.2021.3839. JAMA. 2021. PMID: 33974020 Free PMC article. Clinical Trial.
-
Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders.Int Clin Psychopharmacol. 2020 Jul;35(4):173-193. doi: 10.1097/YIC.0000000000000314. Int Clin Psychopharmacol. 2020. PMID: 32433254 Free PMC article. Review.
-
Quality of life in pediatric patients with obsessive-compulsive disorder during and 3 years after stepped-care treatment.Eur Child Adolesc Psychiatry. 2022 Sep;31(9):1377-1389. doi: 10.1007/s00787-021-01775-w. Epub 2021 Apr 21. Eur Child Adolesc Psychiatry. 2022. PMID: 33881628
References
-
- Asbahr FR, Castillo AR, Ito LM, Latorre MR, Moreira MN, Lotufo-Neto F: Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 44:1128–1136, 2005 - PubMed
-
- Cook EH, Wagner KD, March JS, Biederman J, Landau P, Wolkow R, Messig M: Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 40:1175–1181, 2001 - PubMed
-
- Flament MF, Whitaker A, Rapoport JL, Davies M, Berg CZ, Kalikow K, Sceery W, Shaffer D: Obsessive compulsive disorder in adolescence: An epidemiological study. J Am Acad Child Adolesc Psychiatry 27:764–771, 1988 - PubMed
-
- Gallant J, Storch EA, Merlo LJ, Ricketts ED, Geffken GR, Goodman WK, Murphy TK: Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist. J Anxiety Disord 22:1369–1376, 2008 - PubMed
-
- Geller D, March J: Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 51:98–113, 2012 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical